Functional and MRI Evaluation of the Robot-assisted and Traditional Rehabilitation Programs on the Muscle
1 other identifier
observational
20
1 country
1
Brief Summary
Walk recovery is one of the goals of rehabilitation programs in patients with acquired brain injury. Recent experiences have shown the effectiveness of rehabilitation programs including traditional physiotherapy in combination with robotic gait training systems (Lokomat). In this context, MRI can be used to assess the treatment effects on the muscular tissue, providing useful clinical indications for the optimization of the rehabilitation programs on the basis of the damage extension and the muscle characteristics.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2020
CompletedFirst Submitted
Initial submission to the registry
February 18, 2021
CompletedFirst Posted
Study publicly available on registry
February 24, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedFebruary 24, 2021
February 1, 2021
1.9 years
February 18, 2021
February 22, 2021
Conditions
Outcome Measures
Primary Outcomes (8)
GMFM - T-pre
Gross Motor Function Measures (GMFM) acquired before the beginning of the treatment. (Functional measure)
The week before the beginning of the treatment
6mwt - T-pre
Six minute walking test (6mwt) performed before the beginning of the treatment. (Functional measure)
The week before the beginning of the treatment
Ashowrth scale - T-pre
Ashowrth scale acquired before the beginning of the treatment. (Functional measure)
The week before the beginning of the treatment
Tardieu scale - T-pre
Tardieu scale acquired before the beginning of the treatment. (Functional measure)
The week before the beginning of the treatment
GMFM - T-post
Gross Motor Function Measures (GMFM) acquired after the end of the treatment. (Functional measure)
Within a week after the ent of the treatment
6mwt - T-post
Six minute walking test (6mwt) performed after the end of the treatment. (Functional measure)
Within a week after the ent of the treatment
Ashowrth scale - T-post
Ashowrth scale acquired performed after the end of the treatment. (Functional measure)
Within a week after the ent of the treatment
Tardieu scale - T-post
Tardieu scale acquired performed after the end of the treatment. (Functional measure)
Within a week after the ent of the treatment
Secondary Outcomes (8)
WF - T-pre
The week before the beginning of the treatment
FF - T-pre
The week before the beginning of the treatment
FA - T-pre
The week before the beginning of the treatment
MD - T-pre
The week before the beginning of the treatment
WF - T-post
Within a week after the end of the treatment
- +3 more secondary outcomes
Study Arms (1)
Pediatric patients with acquired brain injury
Subjects with a acquired brain injury occurred in the last 10 months prior the beginning of the treatment
Interventions
Conventional physiotherapy is performed in 10 weekly sessions (45 minutes each) over 4 weeks(total 40 sessions). Specific exercises are administered to improve gait, balance and functional abilities focusing on: strengthening the gluteus and quadriceps muscles stretching the hip flexor and hamstrings muscles increasing static balance increasing dynamic balance increasing functional abilities improving ground gait going up and down the stairs. Physiotherapists can choose from a list of 25 standard exercises, according to some constraints: 1. strengthening exercises had to involve all the lower limb joints (no segmental intervention) 2. during each session, at least 4 out of the 7 categories above had to be delivered 3. the impossibility to perform any of the categories above during any session had to be recorded in the patient's treatment diary. Physiotherapists of the treatments group discuss patients' diaries during weekly meetings.
The rehabilitation protocol consists of 20 sessions of robotic training alternated with 20 sessions of conventional physiotherapy (CP). Each treatment is performed in 5 weekly sessions (45 minutes each) over 4 weeks. Robotic training aimed to recovery/improve walking capacity from the initial Gross Motor Function Classification System (GMFCS) level. It is performed using the Lokomat® (Hocoma AG, Volketswil, Switzerland) gait orthosis. Initial set ups includes 50% body weight unload, gait velocity adjusted on the patient individual capability (1.5 km/h on average) and 100% guidance force. Both weight unload and guidance force are gradually reduced across sessions according to patient recovery of muscle strength and allowing patients to work harden and move more freely. Children engagement, active participation and motivation were reinforced through frequent encouragement by therapists and performance feedback implemented in the exercise video-games.
Eligibility Criteria
The study population includes pediatric patients with acquired brain lesion occurred in the last 10 months prior the beginning of the treatment and showing deficit in the lower limbs movements due to the acquired lesion.
You may qualify if:
- acquired brain lesion occurred in the last 10 months prior the beginning of the treatment
- hemi or tetraparesis diagnosis following the brain lesion
- thigh-bone length \> 21 cm
- ability and willingness to follow instructions and communicate fear and pain
You may not qualify if:
- severe contractures, fractures, bone instability or osteoporosis of the lower limbs
- skin lesions in the lower limbs
- thromboembolic or cardiovascular pathologies
- aggression and self-aggressive behavior
- orthopedic surgery and/or botulinum toxin injection in the 6 months prior to enrollment
- cognitive and/or motor deficits prior to the injury
- contraindications to MRI examination
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- IRCCS Eugenio Medealead
- The National Research Council, Italycollaborator
Study Sites (1)
Scientific Institute IRCCS Eugenio Medea
Bosisio Parini, LC, 23842, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Denis Peruzzo, PhD
Research Institute IRCCS Eugenio Medea
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 18, 2021
First Posted
February 24, 2021
Study Start
January 1, 2020
Primary Completion
November 30, 2021
Study Completion
December 31, 2021
Last Updated
February 24, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share